2026 Q2 -tulosraportti
UUTTA
2 päivää sitten
‧48 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 25.2. | ||
2025 Q3 -tulosraportti 24.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·6 t sitten · MuokattuFor many of us here, momentum in stocks means a lot. And then short-term momentum. The emission late last night completely removed the positive sentiment today, and many are probably going into the weekend with some anger and frustration. There's a lot of speculation, and here's another one: NYKD management resigned a good while back, only to turn around again. They are over-eager to make this fly ✈️ now, otherwise they wouldn't have turned around! I think bigger things are going on. Ref Agnete's over-bullish tone and attitude in the quarterly presentation, and info. DNB Carnegie analyst commented at Hegnar (remember, they haven't come with an updated analysis and price target yet). Shortly, even more positive news will come, and they already have indications of this. I'm buying more in the coming weeks! (4.30 in price - 2.60 per share in cash = 1.7kr per share for everything they have built in now over 20 years. That's a giveaway price, and the trick is not to look at 10-øre coins)It's the "rhetorical short", and I know who it is, who is a bit "needling" 🪡 as one says in poker language. But it's in adversity that one progresses 👆
·7 t sittenStrange if it closes below 4.40 when there was such great interest in this "offer"! A bluff perhaps!?🧐
the investors on the Oslo Stock Exchange saw a rapid decline in the USA in biotech and sold out as an extra safety margin in case of a crash in the USA, which did not happen.
·7 t sittenCan a partnership announcement come after market close today?I was sitting and thinking about it. There was a very nice person here on the forum who shared a video at Hegnar. When the DNB Carnegie analyst is confronted with it earlier today, it seems like he knows something. But, but, maybe it's me who is mistaken 🤷♂️
·7 t sittenNykode Therapeutics has received a draft recommendation from the secretariat of the Tax Appeals Board recommending that the company prevail in the ongoing tax case. Upon a final decision in line with the recommendation, Nykode expects to be reimbursed 325 million kroner, plus interest. This was stated in a message on Wednesday.
Thanks for the info, yes... Would you also bother to give us a post about the emission on Monday?
·8 t sittenI think the whole process with the emission smells like shit. First they increase price targets, then the brokerage firm facilitates the emission. Cannot understand that it is legal....
This is what brokerage firms do! Trust yourself and NEVER them! "Bought and paid for" is probably the best expression here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
UUTTA
2 päivää sitten
‧48 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·6 t sitten · MuokattuFor many of us here, momentum in stocks means a lot. And then short-term momentum. The emission late last night completely removed the positive sentiment today, and many are probably going into the weekend with some anger and frustration. There's a lot of speculation, and here's another one: NYKD management resigned a good while back, only to turn around again. They are over-eager to make this fly ✈️ now, otherwise they wouldn't have turned around! I think bigger things are going on. Ref Agnete's over-bullish tone and attitude in the quarterly presentation, and info. DNB Carnegie analyst commented at Hegnar (remember, they haven't come with an updated analysis and price target yet). Shortly, even more positive news will come, and they already have indications of this. I'm buying more in the coming weeks! (4.30 in price - 2.60 per share in cash = 1.7kr per share for everything they have built in now over 20 years. That's a giveaway price, and the trick is not to look at 10-øre coins)It's the "rhetorical short", and I know who it is, who is a bit "needling" 🪡 as one says in poker language. But it's in adversity that one progresses 👆
- ·7 t sittenStrange if it closes below 4.40 when there was such great interest in this "offer"! A bluff perhaps!?🧐the investors on the Oslo Stock Exchange saw a rapid decline in the USA in biotech and sold out as an extra safety margin in case of a crash in the USA, which did not happen.
- ·7 t sittenCan a partnership announcement come after market close today?I was sitting and thinking about it. There was a very nice person here on the forum who shared a video at Hegnar. When the DNB Carnegie analyst is confronted with it earlier today, it seems like he knows something. But, but, maybe it's me who is mistaken 🤷♂️
- ·7 t sittenNykode Therapeutics has received a draft recommendation from the secretariat of the Tax Appeals Board recommending that the company prevail in the ongoing tax case. Upon a final decision in line with the recommendation, Nykode expects to be reimbursed 325 million kroner, plus interest. This was stated in a message on Wednesday.Thanks for the info, yes... Would you also bother to give us a post about the emission on Monday?
- ·8 t sittenI think the whole process with the emission smells like shit. First they increase price targets, then the brokerage firm facilitates the emission. Cannot understand that it is legal....This is what brokerage firms do! Trust yourself and NEVER them! "Bought and paid for" is probably the best expression here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 25.2. | ||
2025 Q3 -tulosraportti 24.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
2026 Q2 -tulosraportti
UUTTA
2 päivää sitten
‧48 min
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 25.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 25.2. | ||
2025 Q3 -tulosraportti 24.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·6 t sitten · MuokattuFor many of us here, momentum in stocks means a lot. And then short-term momentum. The emission late last night completely removed the positive sentiment today, and many are probably going into the weekend with some anger and frustration. There's a lot of speculation, and here's another one: NYKD management resigned a good while back, only to turn around again. They are over-eager to make this fly ✈️ now, otherwise they wouldn't have turned around! I think bigger things are going on. Ref Agnete's over-bullish tone and attitude in the quarterly presentation, and info. DNB Carnegie analyst commented at Hegnar (remember, they haven't come with an updated analysis and price target yet). Shortly, even more positive news will come, and they already have indications of this. I'm buying more in the coming weeks! (4.30 in price - 2.60 per share in cash = 1.7kr per share for everything they have built in now over 20 years. That's a giveaway price, and the trick is not to look at 10-øre coins)It's the "rhetorical short", and I know who it is, who is a bit "needling" 🪡 as one says in poker language. But it's in adversity that one progresses 👆
- ·7 t sittenStrange if it closes below 4.40 when there was such great interest in this "offer"! A bluff perhaps!?🧐the investors on the Oslo Stock Exchange saw a rapid decline in the USA in biotech and sold out as an extra safety margin in case of a crash in the USA, which did not happen.
- ·7 t sittenCan a partnership announcement come after market close today?I was sitting and thinking about it. There was a very nice person here on the forum who shared a video at Hegnar. When the DNB Carnegie analyst is confronted with it earlier today, it seems like he knows something. But, but, maybe it's me who is mistaken 🤷♂️
- ·7 t sittenNykode Therapeutics has received a draft recommendation from the secretariat of the Tax Appeals Board recommending that the company prevail in the ongoing tax case. Upon a final decision in line with the recommendation, Nykode expects to be reimbursed 325 million kroner, plus interest. This was stated in a message on Wednesday.Thanks for the info, yes... Would you also bother to give us a post about the emission on Monday?
- ·8 t sittenI think the whole process with the emission smells like shit. First they increase price targets, then the brokerage firm facilitates the emission. Cannot understand that it is legal....This is what brokerage firms do! Trust yourself and NEVER them! "Bought and paid for" is probably the best expression here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt